Presentation on
Histamine
Presented by: Presented to:
Rabiya Ahsan Dr. Badruddin
(research scholar) associate professor(Jr.)
Integral University Lucknow
2020-2021
Introduction
• First Autacoid to be discovered. (Greek: autos=self; akos=cure)
• Synthesized in 1907
• Isolated and demonstrated to be a natural constituent of mammalian
tissues (1927); hence the name Histos=Tissue
• H1 was discovered in1966
• H2 in1972
• H3 in1987
• H4 in 2001
Definition:-Chemical messenger that mediates a wide range of cellular
responses, including allergic and inflammatory reactions, gastric acid
secretion, and neurotransmission in parts of the brain. Plays an important
role in gastric acid secretion.
Synthesis, storage and release
Synthesized by decarboxylation of amino acid histidine.
Histamine is present in storage granules of mast cells & also found in
skin, lungs, liver, gastric mucosa etc.
Histamine is released by several mechanism.
• Immunological release
• Chemical and mechanical release
• Loss of granules from mast cells also release histamine since sodium
ions in the extracellular fluids rapidly displace histamine from the
complex.
Mechanism of histamine
Histamine
H1 Receptor H2 Receptor H3 Receptor
Increase Ca2+ Decreased
cAMP
increased
cAMP
• Smooth muscle contraction.
• Increased capillary.
• Permeability.
• Vasodilation.
• Sensory nerve ending pain &
itching
• Increased gastric acid secretion
• Blood vessels
• Vasodilation
• Increased capillary
• permeability
• Decreased histamine
release
• Decreased secretion
• vasodilation
HISTAMINE (Pharmacological Effects/ biological
function)
1. Cardiovascular system. vasodilation
2. Smooth muscle of bronchioles; contraction of nonvascular smooth
muscle.
3. Peripheral Nervous system: itching and pain
4. Exocrine Glands
5. Gastric glands
6. Salivary glands
7. Sweat glands Secretion
8. Pancreas
9. Bronchial glands
10. Lacrimal glands
secretion
Histamine action through its receptors
Types Location Effect Treatment
H1 Throughout body (smooth
muscles, heart, CNS)
Bronchoconstriction,
vasodilation, pain, motion
sickness
Allergies, nausea, sleep
disorder
H2 Specific location in the
body (gastric parietal cell,
vascular smooth muscle,
CNS, heart, uterus
Regulate gastric acid
secretion, vasodilators
Stomach ulcers
H3 CNS, small intestine Neural presynaptic
receptor, may function to
release histamine
unknown
H4 Spleen, thymus,
leukocytes
Mast cell chemotaxis Treatment of
autoimmune diseases like
rheumatoid arthritis
Anti-histaminic agents
• Anti-histaminic agents usually referred to those opposing the H1
mediated effects of histamine.
These are classified as:
• First generation
• Second generation
• Those opposing the H2 mediated effect of histamine are known as
anti-secretory agents.
H1-RECEPTOR ANTAGONISTS (Conventional Antihistaminics)
First generation Antihistaminics
Highly sedative:
• Diphenhydramine
• Dimenhydrinate
• Promethazine
• Hydroxyzine
Moderately sedative:
• Pheniramine
• Cyproheptadine
• Meclizine
• Buclizine
• Cinnarazine
Mild sedative: Chlorpheniramine, Dexchlorpheniramine, Dimethindene,
Triprolidine, Mebhydroline, Cyclizine, Clemastine
Uses:
• Adjunctive in anaphylaxis and other cases where histamine release
can occur.
• Antiallergy
• Prevent motion sickness/antiemetic
• Antitussive
ADR
• Sedation, dizziness, fatigue and antimuscranic effects (dry mouth,
constipation, urinary retention, blurred vision)
• Second generation Antihistaminics: Fexofenadine, Loratadine,
Desloratadine, Cetrizine, Levocetrizine, Azelastine, Mizolastine,
Ebastine, Rupatadine.
Uses:
• Pruritus, allergic rhinitis, urticaria
ADR
• Fatigue, dry mouth, pharyngitis, dizziness and arrhythmia
H2 antihistaminics
• Cimetidine
• Ranitidine
• Famotidine
• Roxatidine
• Primarily used in peptic ulcer and other gastric hypersecretory states
H3 antihistaminics: Thioperamide
No clinical utility.
Mast cell stabilisers (histamine release inhibitors)
Cromolyn and nedocromil.
Dual acting antihistamines (H1 antihistaminic action + mast cell stabilisers)
Azelastine and kitotifen.
Treatment of peptic ulcers/other gastric conditions
Peptic ulcer disease causes can be
• Hypersecretion of acid and pepsin
• Infection due to helicobacter pylori
Other risk factors
• NSAID’s like aspirin, ibuprofen etc
• Cigarette smoking, alcohol consumption, oily and spicy diet
• Emotional stress
Treatment includes
Antacids: aluminium and magnesium hydroxide, NaHCO3
• H2 histamine receptor antagonist- ranitidine
• Protective mucosal barriers- sucralfate, carbenoxolone
• PPIs- omeparazole, pantoparazole
• Prostaglandins-misoprostol
• Muscarinic antagonists- pirenzipine
• Along with antibiotics- if infection with H- pylori
Reference
• JOHN H.BLOCK & JOHN M WILSON& GISVOLD’S Organic Medicinal &
Pharmaceutical chemistry. (Pg): 698 – 728
• D.SRIRAM & P.YOGEESWARI -Medicinal chemistry. (Pg): 278 – 302
• BERTRAM G.KATZUNG, SUSAN B.MARTERS ANTHONY J.TREVOR Basic
& Clinical pharmacology (Pg) : 277
• K.D TRIPATHI Essentials of medical pharmacology. (Pg): 159 – 160.

Histamine

  • 1.
    Presentation on Histamine Presented by:Presented to: Rabiya Ahsan Dr. Badruddin (research scholar) associate professor(Jr.) Integral University Lucknow 2020-2021
  • 2.
    Introduction • First Autacoidto be discovered. (Greek: autos=self; akos=cure) • Synthesized in 1907 • Isolated and demonstrated to be a natural constituent of mammalian tissues (1927); hence the name Histos=Tissue • H1 was discovered in1966 • H2 in1972 • H3 in1987 • H4 in 2001 Definition:-Chemical messenger that mediates a wide range of cellular responses, including allergic and inflammatory reactions, gastric acid secretion, and neurotransmission in parts of the brain. Plays an important role in gastric acid secretion.
  • 3.
    Synthesis, storage andrelease Synthesized by decarboxylation of amino acid histidine. Histamine is present in storage granules of mast cells & also found in skin, lungs, liver, gastric mucosa etc. Histamine is released by several mechanism. • Immunological release • Chemical and mechanical release • Loss of granules from mast cells also release histamine since sodium ions in the extracellular fluids rapidly displace histamine from the complex.
  • 4.
    Mechanism of histamine Histamine H1Receptor H2 Receptor H3 Receptor Increase Ca2+ Decreased cAMP increased cAMP • Smooth muscle contraction. • Increased capillary. • Permeability. • Vasodilation. • Sensory nerve ending pain & itching • Increased gastric acid secretion • Blood vessels • Vasodilation • Increased capillary • permeability • Decreased histamine release • Decreased secretion • vasodilation
  • 5.
    HISTAMINE (Pharmacological Effects/biological function) 1. Cardiovascular system. vasodilation 2. Smooth muscle of bronchioles; contraction of nonvascular smooth muscle. 3. Peripheral Nervous system: itching and pain 4. Exocrine Glands 5. Gastric glands 6. Salivary glands 7. Sweat glands Secretion 8. Pancreas 9. Bronchial glands 10. Lacrimal glands secretion
  • 6.
    Histamine action throughits receptors Types Location Effect Treatment H1 Throughout body (smooth muscles, heart, CNS) Bronchoconstriction, vasodilation, pain, motion sickness Allergies, nausea, sleep disorder H2 Specific location in the body (gastric parietal cell, vascular smooth muscle, CNS, heart, uterus Regulate gastric acid secretion, vasodilators Stomach ulcers H3 CNS, small intestine Neural presynaptic receptor, may function to release histamine unknown H4 Spleen, thymus, leukocytes Mast cell chemotaxis Treatment of autoimmune diseases like rheumatoid arthritis
  • 7.
    Anti-histaminic agents • Anti-histaminicagents usually referred to those opposing the H1 mediated effects of histamine. These are classified as: • First generation • Second generation • Those opposing the H2 mediated effect of histamine are known as anti-secretory agents.
  • 8.
    H1-RECEPTOR ANTAGONISTS (ConventionalAntihistaminics) First generation Antihistaminics Highly sedative: • Diphenhydramine • Dimenhydrinate • Promethazine • Hydroxyzine Moderately sedative: • Pheniramine • Cyproheptadine • Meclizine • Buclizine • Cinnarazine Mild sedative: Chlorpheniramine, Dexchlorpheniramine, Dimethindene, Triprolidine, Mebhydroline, Cyclizine, Clemastine
  • 9.
    Uses: • Adjunctive inanaphylaxis and other cases where histamine release can occur. • Antiallergy • Prevent motion sickness/antiemetic • Antitussive ADR • Sedation, dizziness, fatigue and antimuscranic effects (dry mouth, constipation, urinary retention, blurred vision)
  • 10.
    • Second generationAntihistaminics: Fexofenadine, Loratadine, Desloratadine, Cetrizine, Levocetrizine, Azelastine, Mizolastine, Ebastine, Rupatadine. Uses: • Pruritus, allergic rhinitis, urticaria ADR • Fatigue, dry mouth, pharyngitis, dizziness and arrhythmia
  • 11.
    H2 antihistaminics • Cimetidine •Ranitidine • Famotidine • Roxatidine • Primarily used in peptic ulcer and other gastric hypersecretory states H3 antihistaminics: Thioperamide No clinical utility. Mast cell stabilisers (histamine release inhibitors) Cromolyn and nedocromil. Dual acting antihistamines (H1 antihistaminic action + mast cell stabilisers) Azelastine and kitotifen.
  • 12.
    Treatment of pepticulcers/other gastric conditions Peptic ulcer disease causes can be • Hypersecretion of acid and pepsin • Infection due to helicobacter pylori Other risk factors • NSAID’s like aspirin, ibuprofen etc • Cigarette smoking, alcohol consumption, oily and spicy diet • Emotional stress Treatment includes Antacids: aluminium and magnesium hydroxide, NaHCO3
  • 13.
    • H2 histaminereceptor antagonist- ranitidine • Protective mucosal barriers- sucralfate, carbenoxolone • PPIs- omeparazole, pantoparazole • Prostaglandins-misoprostol • Muscarinic antagonists- pirenzipine • Along with antibiotics- if infection with H- pylori
  • 14.
    Reference • JOHN H.BLOCK& JOHN M WILSON& GISVOLD’S Organic Medicinal & Pharmaceutical chemistry. (Pg): 698 – 728 • D.SRIRAM & P.YOGEESWARI -Medicinal chemistry. (Pg): 278 – 302 • BERTRAM G.KATZUNG, SUSAN B.MARTERS ANTHONY J.TREVOR Basic & Clinical pharmacology (Pg) : 277 • K.D TRIPATHI Essentials of medical pharmacology. (Pg): 159 – 160.